The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|12|3|221-235

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.3, 2012-09, pp. : 221-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Strategies for Immune-Mediated Anti-Viral Drug and Vaccine Development

By  

Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. : 1391-1401

Bentham Science Publishers

Access to resources Recommend Favorite

Bacterial Proteomics and Vaccine Development

By Nilsson C.L.  

American Journal of PharmacoGenomics, Vol. 2, Iss. 1, 2002-01 ,pp. : 59-65

Adis International

Access to resources Recommend Favorite

Lactoferrin as a Natural Immune Modulator

By  

Current Pharmaceutical Design, Vol. 15, Iss. 17, 2009-01 ,pp. : 1956-1973

Bentham Science Publishers

Access to resources Recommend Favorite

Current Advances in the Identification and Characterization of Putative Drug and Vaccine Targets in the Bacterial Genomes

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 1040-1069

Bentham Science Publishers

Access to resources Recommend Favorite

Attenuation of endothelium-dependent hyperpolarizing factor by bacterial lipopolysaccharides

By Kristof A.S.   Noorhosseini H.   Hussain S.N.A.  

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite